Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drug

Mille B. L. Kryger, Benjamin M. Wohl, Anton A. A. Smith, Alexander N. Zelikin
  • Chemical Communications, January 2013, Royal Society of Chemistry
  • DOI: 10.1039/c3cc00315a
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: